Genpact (NYSE:G - Get Free Report) issued an update on its second quarter 2026 earnings guidance on Thursday morning. The company provided EPS guidance of 0.960-0.970 for the period, compared to the consensus EPS estimate of 0.950. The company issued revenue guidance of $1.3 billion-$1.3 billion, compared to the consensus revenue estimate of $1.3 billion.
Genpact Stock Performance
NYSE:G traded up $0.62 during trading on Thursday, reaching $34.42. The company's stock had a trading volume of 3,376,868 shares, compared to its average volume of 2,363,670. Genpact has a 12 month low of $33.12 and a 12 month high of $48.64. The firm has a market cap of $5.84 billion, a price-to-earnings ratio of 11.00, a price-to-earnings-growth ratio of 1.00 and a beta of 0.61. The firm has a 50 day moving average of $37.34 and a 200-day moving average of $41.39. The company has a debt-to-equity ratio of 0.46, a quick ratio of 1.66 and a current ratio of 1.66.
Genpact (NYSE:G - Get Free Report) last issued its quarterly earnings results on Thursday, May 7th. The business services provider reported $0.98 earnings per share for the quarter, topping analysts' consensus estimates of $0.93 by $0.05. The company had revenue of $1.30 billion for the quarter, compared to the consensus estimate of $1.29 billion. Genpact had a net margin of 10.88% and a return on equity of 22.02%. Genpact has set its Q2 2026 guidance at 0.960-0.970 EPS. Research analysts expect that Genpact will post 3.6 EPS for the current fiscal year.
Genpact Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, June 25th. Investors of record on Wednesday, June 10th will be paid a $0.1875 dividend. The ex-dividend date is Wednesday, June 10th. This represents a $0.75 annualized dividend and a yield of 2.2%. Genpact's dividend payout ratio is presently 23.96%.
Analyst Upgrades and Downgrades
Several analysts have issued reports on G shares. Needham & Company LLC lowered their target price on Genpact from $53.00 to $50.00 and set a "buy" rating on the stock in a research note on Friday, February 6th. Mizuho reduced their target price on shares of Genpact from $51.00 to $49.00 and set a "neutral" rating for the company in a research note on Tuesday, February 10th. Wall Street Zen lowered shares of Genpact from a "buy" rating to a "hold" rating in a research report on Saturday, March 14th. Susquehanna cut their price objective on shares of Genpact from $42.00 to $37.00 and set a "neutral" rating for the company in a report on Tuesday. Finally, Citigroup upgraded shares of Genpact from a "hold" rating to a "strong-buy" rating in a research note on Friday, February 13th. One equities research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and six have given a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of "Hold" and an average price target of $46.57.
Check Out Our Latest Stock Analysis on Genpact
Insiders Place Their Bets
In other Genpact news, CEO Balkrishan Kalra sold 2,800 shares of the stock in a transaction that occurred on Wednesday, March 4th. The shares were sold at an average price of $40.77, for a total value of $114,156.00. Following the sale, the chief executive officer directly owned 525,007 shares in the company, valued at $21,404,535.39. This represents a 0.53% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 1.58% of the company's stock.
Institutional Investors Weigh In On Genpact
Several large investors have recently added to or reduced their stakes in G. Johnson Financial Group Inc. bought a new position in Genpact in the 3rd quarter worth about $29,000. iSAM Funds UK Ltd bought a new stake in shares of Genpact during the 3rd quarter valued at about $29,000. Los Angeles Capital Management LLC purchased a new position in shares of Genpact during the fourth quarter worth about $33,000. CIBC Private Wealth Group LLC increased its position in shares of Genpact by 79.9% in the fourth quarter. CIBC Private Wealth Group LLC now owns 750 shares of the business services provider's stock worth $35,000 after purchasing an additional 333 shares during the last quarter. Finally, Northwestern Mutual Wealth Management Co. raised its stake in Genpact by 47.5% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 823 shares of the business services provider's stock valued at $39,000 after purchasing an additional 265 shares in the last quarter. Institutional investors own 96.03% of the company's stock.
Genpact Company Profile
(
Get Free Report)
Genpact is a global professional services firm specializing in digitally powered business process management and services. The company partners with clients across industries to design, transform and run key operations, leveraging data analytics, artificial intelligence, automation and domain expertise. Its offerings span finance and accounting, supply chain management, procurement, customer experience, risk and compliance, and other critical business functions.
Founded in 1997 as the business process outsourcing arm of General Electric and originally known as GE Capital International Services, the company rebranded as Genpact in 2005 and completed its initial public offering on the New York Stock Exchange in 2007 under the ticker symbol “G.” Over time, Genpact has expanded beyond traditional outsourcing to focus on digital transformation and innovation, helping organizations accelerate growth and improve operational efficiency.
Headquartered in New York City, Genpact serves clients in more than 30 countries across North America, Latin America, Europe and Asia Pacific.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead.
This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.